Home
Recent press, briefings and insights helping you stay informed on AliveDx newest launch.
Alba Bioscience Inc., part of the AliveDx group, is pleased to announce a distribution agreement with RAF Solutions LA, Inc. to bring its high-quality blood bank reagents to the Latin American market. This strategic partnership reinforces Alba’s commitment to expanding
AliveDx Suisse S.A. and Tabrane Pharmaceuticals (PVT) Limited have signed a distribution agreement, which will enable Tabrane Pharmaceuticals to distribute the MosaiQ® solution in Sri Lanka. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and
We are proud to announce that our abstract B-073, titled: “Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases” has been awarded the ADLM 2024 Industry
AliveDx Suisse S.A. and Kyungil Hi-tec INC have signed an exclusive distribution agreement, which will enable Kyungil Hi-tec to distribute the MosaiQ® solution in South Korea. The distribution agreement takes effect immediately. This strategic partnership with an important partner in
AliveDx Suisse S.A. and PZ Cormay S.A. have signed a distribution agreement, which will enable PZ Cormay to distribute the MosaiQ® solution in Poland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach and presence across
We are excited to announce our participation in the upcoming ADLM 2024 Congress, from July 30 to August 1, 2024, in Chicago, USA. Visit us at booth #4055 to learn more about our high-quality blood bank reagents, and the latest
AliveDx Suisse S.A. and Prolab IVD S.R.L. have signed a distribution agreement, which will enable Prolab to distribute the MosaiQ® solution in Romania. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening its global footprint and
AliveDx Suisse S.A. and BioAnalytica S.A. have signed a distribution agreement, which will enable BioAnalytica to distribute the MosaiQ® solution in Greece and Cyprus. The distribution agreement takes effect immediately. This strategic partnership underscores AliveDx’s commitment to expanding its geographical
AliveDx Suisse S.A. and Axon Lab AG have signed a distribution agreement, which will enable Axon Lab to distribute the MosaiQ® solution in Austria, Germany and Switzerland. The distribution agreement takes effect immediately. AliveDx is dedicated to expanding its reach
AliveDx recently partnered with the Great Place To Work organization to support our journey toward becoming an exceptional workplace for all our employees. Our goal is to foster a sense of belonging, instill pride in the work we do, and